Opsoclonus–myoclonus–ataxia syndrome with autoantibodies to glutamic acid decarboxylase
Authors:
- Ioannis MarkakisIMIoannis Markakis
- Eleni AlexiouEAEleni Alexiou
- Michael XifarasMXMichael Xifaras
- Georgios GekasGGGeorgios Gekas
- Antoniοs RombosARAntoniοs Rombos
- 1 June 2008
- journal article
- case report
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 110 (6) , 619-621
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Chronic relapsing opsoclonus-myoclonus syndrome: Combination of cyclophosphamide and dexamethasone pulsesEuropean Journal of Paediatric Neurology, 2008
- B- and T-cell markers in opsoclonus–myoclonus syndromeNeurology, 2004
- Autoantigen diversity in the opsoclonus‐myoclonus syndromeAnnals of Neurology, 2003
- Glutamic acid decarboxylase autoantibodies and neurological disordersNeurological Sciences, 2002
- Cerebellar ataxia with glutamic acid decarboxylase autoantibodiesNeurology, 1999
- International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndromeJournal of the Neurological Sciences, 1997
- Treatment of opsoclonus-myoclonus with highdose intravenous immunoglobulinNeurology, 1996
- Autoantibodies to glutamic acid decarboxylase in palatal myoclonus and epilepsyAnnals of Neurology, 1994
- The Neurobiology of the Opsoclonus-Myoclonus SyndromeClinical Neuropharmacology, 1992
- Autoantibodies to GABA-ergic Neurons and Pancreatic Beta Cells in Stiff-Man SyndromeNew England Journal of Medicine, 1990